Endometriosis affects millions of women worldwide, with estimates suggesting that up to 10% of women of reproductive age may have the condition. Despite this, endometriosis remains a difficult condition to diagnose, often leaving women struggling with debilitating pain and other symptoms for years before receiving a proper diagnosis.
One of the main reasons that endometriosis is so difficult to diagnose is because its symptoms can vary greatly from person to person. While some women may experience severe pain, others may have no symptoms at all. This can make it difficult for doctors to identify the condition and distinguish it from other causes of pelvic pain. In addition, the gold standard for diagnosis, laparoscopic surgery, can be expensive, invasive, and carry risks.
The psychological effects of having undiagnosed pain and being dismissed by doctors can be devastating. Women with endometriosis may feel frustrated, helpless, and isolated, and may even start to question their own experiences and sanity. This can lead to depression, anxiety, and other mental health issues, which can further exacerbate the physical symptoms of the condition.
So, what is the benefit of being diagnosed with endometriosis when there is no cure? Despite the lack of a cure, a proper diagnosis can be life-changing for women with endometriosis. It can provide validation for their experiences, help them access appropriate treatment and management options, and offer a sense of control and empowerment over their own bodies and health.
This is where the EndoSure test comes in. The EndoSure test is a non-invasive diagnostic tool that can provide accurate and immediate results for endometriosis, without the need for surgery. This revolutionary technology can provide women with the validation, treatment options, and sense of control they need to manage their condition effectively.
This Endometriosis Awareness Month, let us continue to raise awareness about this condition and advocate for better diagnostic tools and treatment options. With the EndoSure test, we can offer hope and empowerment to women living with endometriosis, and work towards a future where no woman has to suffer in silence ... it's about time.
About Us
EndoSure offers the only non-invasive, 30-minute test to support the diagnosis of endometriosis that not only fills the gap, but addresses the vacuum in this area of women’s health care.*
© July 2024 ENDOSURE, Inc. All rights reserved
site design by
Boston Web Partners
Contact Information
954 Ridgebrook Road
Sparks Glencoe, Maryland 21152
1. Approximately 15-20 minutes of patient preparation time may be required prior to performing the test.
2. Mathias JR, Franklin R, Quast DC, Fraga N, Loftin CA, Yates L, Harrison V. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril. 1998 Jul;70(1):81-8.
3. i. Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. J Clin Med. 2024 May 13;13(10):2866. doi: 10.3390/jcm13102866. PMID: 38792407; PMCID: PMC11122642.
4. Zondervan, K.T.; Becker, C.M.; Koga, K.; Missmer, S.A.; Taylor, R.N.; Viganò, P. Endometriosis. Nat. Rev. Dis. Primers. 2018:4-9.
5. 1. Noar M, Mathias J, Kolatkar A. Validation of New GIMA Biomarker Signature of Endometriosis - Interim Data: Research Article. TechRxiv. August 26, 2024. DOI: 10.22541/au.172469630.08159498/v1
6. 1. Kitsantas P, Benson KN, Al-Farauki S, Knecht MK, Hennekens CH, et al. (2024) Emerging Diagnostic Tools for the Early Diagnosis of Endometriosis. J Reprod Med Gynecol Obstet 9: 171.
DISCLAIMER: THE ENDOSURE TEST IS A CLINICAL DECISION SUPPORT TOOL INTENDED TO INFORM AND ENHANCE A HEALTHCARE PROVIDER'S DECISION-MAKING PROCESS, WHICH MUST BE INDIVIDUALIZED FOR EACH PATIENT'S CIRCUMSTANCES AND TAKE INTO ACCOUNT THE FULL SCOPE OF MEDICAL DATA AND INFORMATION AVAILABLE TO THE PROVIDER. THE ENDOSURE TEST IS NOT INTENDED TO SUBSTITUTE, REPLACE, OVERRULE, OR DIRECT A HEALTHCARE PROVIDER’S JUDGMENT.
443-391-7500
* US CUSTOMERS: Endosure is currently available for research use only and not clinical use.